Literature DB >> 9144770

Template-based docking of a prolactin receptor proline-rich motif octapeptide to FKBP12: implications for cytokine receptor signaling.

K V Soman1, B A Hanks, H Tien, M V Chari, K D O'Neal, J D Morrisett.   

Abstract

A conserved proline-rich motif (PRM) in the cytoplasmic domain of cytokine receptors has been suggested to be a signaling switch regulated by the action of the FK506 binding protein (FKBP) family of peptidylprolyl isomerases (O'Neal KD, Yu-Lee LY, Shearer WT, 1995, Ann NY Acad Sci 766:282-284). We have docked the prolactin receptor PRM (Ile1-Phe2-Pro3-Pro4-Val5-Pro6-Gly7-Pro8) to the ligand binding site of FKBP12. The procedure involved conformational search restricted by NMR restraints (O'Neal KD et al., 1996, Biochem J 315:833-844), energy minimization of the octapeptide conformers so obtained, template-based docking of a selected conformer to FKBP12, and energy refinement of the resulting complex. The template used was the crystal structure of a cyclic FK506-peptide hybrid bound to FKBP12. Val5-Pro6 of the PRM was taken to be the biologically relevant Xaa-Pro bond. The docked conformer is stabilized by two intramolecular hydrogen bonds, N7H7-->O4 and N2H2-->O8, and two intermolecular ones, Ile56; N-H-->O = C:Pro6 and Tyr82:O-H-->O = C:Gly7. This conformer features a Type I beta-turn and has extensive hydrophobic contacts with the FKBP12 binding surface. The observed interactions support the hypothesis that FKBP12 catalyzes cis-trans isomerization in the PRM when it is part of the longer cytoplasmic domain of a cytokine receptor, and suggest a significant role for the PRM in signal transduction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144770      PMCID: PMC2143701          DOI: 10.1002/pro.5560060505

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  22 in total

1.  Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex.

Authors:  G D Van Duyne; R F Standaert; P A Karplus; S L Schreiber; J Clardy
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

2.  Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin.

Authors:  S W Michnick; M K Rosen; T J Wandless; M Karplus; S L Schreiber
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

3.  Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo.

Authors:  T Okadome; E Oeda; M Saitoh; H Ichijo; H L Moses; K Miyazono; M Kawabata
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

4.  Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system.

Authors:  P Dauber-Osguthorpe; V A Roberts; D J Osguthorpe; J Wolff; M Genest; A T Hagler
Journal:  Proteins       Date:  1988

5.  A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain.

Authors:  J F Bazan
Journal:  Biochem Biophys Res Commun       Date:  1989-10-31       Impact factor: 3.575

6.  Chain reversals in proteins.

Authors:  P N Lewis; F A Momany; H A Scheraga
Journal:  Biochim Biophys Acta       Date:  1973-04-20

7.  Stereochemical criteria for polypeptides and proteins. V. Conformation of a system of three linked peptide units.

Authors:  C M Venkatachalam
Journal:  Biopolymers       Date:  1968-10       Impact factor: 2.505

8.  Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes.

Authors:  R K Harrison; R L Stein
Journal:  Biochemistry       Date:  1990-04-24       Impact factor: 3.162

9.  Mechanistic studies of peptidyl prolyl cis-trans isomerase: evidence for catalysis by distortion.

Authors:  R K Harrison; R L Stein
Journal:  Biochemistry       Date:  1990-02-20       Impact factor: 3.162

10.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.